PRESS RELEASES
In Support of WHO Schistosomiasis Control and Elimination Programs: Progressing a TPP-compliant serological test for Schistosoma mansoni to Field Testing and Manufacturing Process Development (GHIT Fund, 18 March 2025): https://www.ghitfund.org/investment/portfoliodetail/detail/235/en
A First-in-class, Fully TPP-compliant Rapid Diagnostic Test for Trachoma Surveillance: Delivering the Missing Piece in WHO’s Worldwide Trachoma Elimination Efforts (GHIT Fund, 7 November 2024): https://www.ghitfund.org/investment/portfoliodetail/detail/223/en
New York Blood Center Enterprises Grants Exclusive License to Big Eye Diagnostics for Diagnostic Biomarkers in River Blindness (New York Blood Center, 01 November 2023):